# FDA Warning Letter: Inopak, Ltd.
> 2024-01-02 · Division of Pharmaceutical Quality Operations I · `cb5da028eed0f662`
## Letter
- **Company:** Inopak, Ltd.
- **Posted Date:** 2024-01-02
- **Letter Issue Date:** 2023-12-15
- **Issuing Office:** Division of Pharmaceutical Quality Operations I
## Subject
CGMP/Finished Pharmaceuticals/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*